FENDRIX

This brand name is authorized in Austria, Croatia, Estonia, Ireland, Lithuania, Netherlands, Poland, Spain, UK.

Active ingredients

The drug FENDRIX contains one active pharmaceutical ingredient (API):

1	Hepatitis B, purified antigen UNII IFJ010MNE4 - HEPATITIS B VIRUS HBSAG SURFACE PROTEIN ANTIGEN
	Hepatitis B vaccine induces specific humoral antibodies against hepatitis B virus surface antigen (anti-HBsAg). Hepatitis B vaccine has been recognized as the first anti-cancer vaccine because it can prevent primary liver cancer.
	Read more about Hepatitis B, purified antigen

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
FENDRIX Suspension for injection	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J07BC01	Hepatitis B, purified antigen	J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BC Hepatitis vaccines
Discover more medicines within J07BC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1223828, 1227024, 1455791
ES	Centro de información online de medicamentos de la AEMPS	04299001
GB	Medicines & Healthcare Products Regulatory Agency	95565
LT	Valstybinė vaistų kontrolės tarnyba	1028400, 1028401, 1028402
NL	Z-Index G-Standaard, PRK	83860
PL	Rejestru Produktów Leczniczych	100133650